Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trialChigusa Morizane, Junji Furuse, Kazuya Sugimori et al.|Annals of Oncology|2019Cited by 333
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall SurvivalYu Sawada, Tetsuya Nakatsura, Toshiaki Yoshikawa et al.|Clinical Cancer Research|2012Cited by 299
Chemotherapy for hepatocellular carcinoma: current status and future perspectivesMasafumi Ikeda, Junji Furuse, Chigusa Morizane et al.|Japanese Journal of Clinical Oncology|2017Cited by 274
EP.12H.09 Phase 1b/2a Study of ATR Inhibitor Tuvusertib + Anti-PD-1 Cemiplimab in Patients with Advanced Non-Squamous NSCLCNatalie I. Vokes, L.C. Villaruz, L. Paz-Ares et al.|Journal of Thoracic Oncology|2024Cited by 0